BackAlamar Biosciences Overview

Alamar Biosciences Other Current Liabilities

Track Alamar Biosciences's other current liabilities ($12M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$11.89M

Peer trimmed avg / median

Loading

Alamar Biosciences Other Current Liabilities History

Loading

Alamar Biosciences vs. peers: Other Current Liabilities Comparison

Loading

Alamar Biosciences Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Alamar Biosciences (ALMR) FAQ

Alamar Biosciences (ALMR) currently reports a other current liabilities of $12M as of June 2026. Use the charts on this page to explore Alamar Biosciences's other current liabilities history and peer comparisons.

Alamar Biosciences reported $12M in other current liabilities as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alamar Biosciences, and consider following ALMR for alerts when major investors trade the stock.

Alamar Biosciences is classified in the Healthcare sector. On other current liabilities, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALMR with unrelated industries.